[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ITMI992693A0 - Derivati di 2-(1h-indol-3il)-2-oxo-acetammidi ad attivita' antitumoral e - Google Patents

Derivati di 2-(1h-indol-3il)-2-oxo-acetammidi ad attivita' antitumoral e

Info

Publication number
ITMI992693A0
ITMI992693A0 IT99MI002693A ITMI992693A ITMI992693A0 IT MI992693 A0 ITMI992693 A0 IT MI992693A0 IT 99MI002693 A IT99MI002693 A IT 99MI002693A IT MI992693 A ITMI992693 A IT MI992693A IT MI992693 A0 ITMI992693 A0 IT MI992693A0
Authority
IT
Italy
Prior art keywords
acetammides
indol
oxo
derivatives
cancer activity
Prior art date
Application number
IT99MI002693A
Other languages
English (en)
Inventor
Nicoletta Pescalli
Ernesto Menta
Original Assignee
Novuspharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novuspharma Spa filed Critical Novuspharma Spa
Publication of ITMI992693A0 publication Critical patent/ITMI992693A0/it
Priority to IT1999MI002693A priority Critical patent/IT1315267B1/it
Priority to KR1020027007960A priority patent/KR100795533B1/ko
Priority to DE60022227T priority patent/DE60022227T2/de
Priority to IL15032900A priority patent/IL150329A0/xx
Priority to BR0016553-0A priority patent/BR0016553A/pt
Priority to EP00985225A priority patent/EP1244652B1/en
Priority to EA200200558A priority patent/EA004925B1/ru
Priority to CZ20022170A priority patent/CZ20022170A3/cs
Priority to ES00985225T priority patent/ES2246918T3/es
Priority to PL00356541A priority patent/PL356541A1/xx
Priority to TR2002/01613T priority patent/TR200201613T2/xx
Priority to HU0203524A priority patent/HUP0203524A3/hu
Priority to AT00985225T priority patent/ATE302772T1/de
Priority to NZ519689A priority patent/NZ519689A/en
Priority to US10/149,406 priority patent/US6753342B2/en
Priority to MXPA02006217A priority patent/MXPA02006217A/es
Priority to CNB00817492XA priority patent/CN1250542C/zh
Priority to CA002395205A priority patent/CA2395205A1/en
Priority to SK896-2002A priority patent/SK285682B6/sk
Priority to JP2001549386A priority patent/JP2003519140A/ja
Priority to AU21704/01A priority patent/AU776332B2/en
Priority to PCT/EP2000/013068 priority patent/WO2001047916A1/en
Publication of ITMI992693A1 publication Critical patent/ITMI992693A1/it
Priority to IL150329A priority patent/IL150329A/en
Priority to ZA200204964A priority patent/ZA200204964B/en
Priority to NO20022976A priority patent/NO323312B1/no
Application granted granted Critical
Publication of IT1315267B1 publication Critical patent/IT1315267B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT1999MI002693A 1999-12-23 1999-12-23 Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale IT1315267B1 (it)

Priority Applications (25)

Application Number Priority Date Filing Date Title
IT1999MI002693A IT1315267B1 (it) 1999-12-23 1999-12-23 Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
AT00985225T ATE302772T1 (de) 1999-12-23 2000-12-21 2-(1h-indol-3-yl)-2-oxo-acetamide mit antitumoraler wirkung
US10/149,406 US6753342B2 (en) 1999-12-23 2000-12-21 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
IL15032900A IL150329A0 (en) 1999-12-23 2000-12-21 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
BR0016553-0A BR0016553A (pt) 1999-12-23 2000-12-21 2-(1h-indol-3-il)-2-oxo-acetamidas com atividades antitumor
EP00985225A EP1244652B1 (en) 1999-12-23 2000-12-21 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
EA200200558A EA004925B1 (ru) 1999-12-23 2000-12-21 2-(1h-индол-3-ил)-2-оксоацетамиды, обладающие противоопухолевой активностью
CZ20022170A CZ20022170A3 (cs) 1999-12-23 2000-12-21 2-(1H-indol-3-yl)-2 oxoacetamidové sloučeniny
ES00985225T ES2246918T3 (es) 1999-12-23 2000-12-21 2-(1h-indol-3-yl)-2-oxo-acetamidas con actividad antitumoral.
PL00356541A PL356541A1 (en) 1999-12-23 2000-12-21 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
TR2002/01613T TR200201613T2 (tr) 1999-12-23 2000-12-21 Antitümör tesirli 2-(1H-indol-3-il)-2-okso asetamidler
HU0203524A HUP0203524A3 (en) 1999-12-23 2000-12-21 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity, their use and pharmaceutical compositions containing them
KR1020027007960A KR100795533B1 (ko) 1999-12-23 2000-12-21 항종양 활성을 갖는 2-(1ｈ-인돌-3-일)-2-옥소-아세트아미드
NZ519689A NZ519689A (en) 1999-12-23 2000-12-21 2-(1H-indol-3-yl)-2-oxo-acetamides with antitumor activity
DE60022227T DE60022227T2 (de) 1999-12-23 2000-12-21 2-(1h-indol-3-yl)-2-oxo-acetamide mit antitumoraler wirkung
MXPA02006217A MXPA02006217A (es) 1999-12-23 2000-12-21 2-(ih-indol-3-il)-2-oxo-acetamidas con actividad antitumoral.
CNB00817492XA CN1250542C (zh) 1999-12-23 2000-12-21 具有抗肿瘤活性的2－(1h－吲哚－3－基)－2－氧代－乙酰胺
CA002395205A CA2395205A1 (en) 1999-12-23 2000-12-21 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
SK896-2002A SK285682B6 (sk) 1999-12-23 2000-12-21 2-(1H-Indol-3-yl)-2-oxo-acetamidy, farmaceutický prostriedok s ich obsahom a ich použitie
JP2001549386A JP2003519140A (ja) 1999-12-23 2000-12-21 抗腫瘍活性を有する２−（１ｈ−インドール−３−イル）−２−オキソ−アセトアミド
AU21704/01A AU776332B2 (en) 1999-12-23 2000-12-21 2-(1H-indol-3-yl)-2-oxo-acetamides with antitumor activity
PCT/EP2000/013068 WO2001047916A1 (en) 1999-12-23 2000-12-21 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
IL150329A IL150329A (en) 1999-12-23 2002-06-19 H1) - 2 - Indole – 3 – Eyal) - 2 - Oxo - acetamides with antisertic activity
ZA200204964A ZA200204964B (en) 1999-12-23 2002-06-20 2-(1H-Indol-3-yl)-2-oxo-acetamides with antitumor activity.
NO20022976A NO323312B1 (no) 1999-12-23 2002-06-20 2-(1H-indol-3yl)-2-okso-acetamider, sammensetninger inneholdende disse og deres anvendelse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI002693A IT1315267B1 (it) 1999-12-23 1999-12-23 Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale

Publications (3)

Publication Number Publication Date
ITMI992693A0 true ITMI992693A0 (it) 1999-12-23
ITMI992693A1 ITMI992693A1 (it) 2001-06-23
IT1315267B1 IT1315267B1 (it) 2003-02-03

Family

ID=11384182

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI002693A IT1315267B1 (it) 1999-12-23 1999-12-23 Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale

Country Status (24)

Country Link
US (1) US6753342B2 (it)
EP (1) EP1244652B1 (it)
JP (1) JP2003519140A (it)
KR (1) KR100795533B1 (it)
CN (1) CN1250542C (it)
AT (1) ATE302772T1 (it)
AU (1) AU776332B2 (it)
BR (1) BR0016553A (it)
CA (1) CA2395205A1 (it)
CZ (1) CZ20022170A3 (it)
DE (1) DE60022227T2 (it)
EA (1) EA004925B1 (it)
ES (1) ES2246918T3 (it)
HU (1) HUP0203524A3 (it)
IL (2) IL150329A0 (it)
IT (1) IT1315267B1 (it)
MX (1) MXPA02006217A (it)
NO (1) NO323312B1 (it)
NZ (1) NZ519689A (it)
PL (1) PL356541A1 (it)
SK (1) SK285682B6 (it)
TR (1) TR200201613T2 (it)
WO (1) WO2001047916A1 (it)
ZA (1) ZA200204964B (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ507406A (en) 1998-04-28 2002-11-26 Dresden Arzneimittel New hydroxyindoles, their use as phosphodiesterase 4 (PDE4) inhibitors and a method of preparation
IT1318641B1 (it) * 2000-07-25 2003-08-27 Novuspharma Spa Ammidi di acidi 2-(1h-indol-3-il)-2-oxo-acetici ad attivita'antitumorale.
DE10037310A1 (de) 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
WO2004005277A1 (en) * 2002-07-09 2004-01-15 Fasgen, Inc. Novel compunds, pharmaceutical compositions containing same, and methods of use for same
US7749999B2 (en) 2003-09-11 2010-07-06 Itherx Pharmaceuticals, Inc. Alpha-ketoamides and derivatives thereof
CA2558545C (en) * 2004-03-11 2012-10-16 Actelion Pharmaceuticals Ltd Indol-1-yl-acetic acid derivatives
US10022352B2 (en) 2006-04-07 2018-07-17 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
HUE055205T2 (hu) 2006-04-07 2021-11-29 Vertex Pharma ATP-kötõ kazetta transzporterek modulátorainak elõállítása
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
CA2660704A1 (en) * 2006-08-07 2008-02-14 Ironwood Pharmaceuticals, Inc. Indole compounds
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
NZ603721A (en) 2010-04-22 2014-11-28 Vertex Pharma Process of producing cycloalkylcarboxamido-indole compounds
AR084433A1 (es) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc Inhibidores de la faah y composiciones farmaceuticas que los contienen
WO2012135027A2 (en) * 2011-03-25 2012-10-04 The Research Foundation Of State University Of New York Thiolactone antibiotics
EP2872122A1 (en) 2012-07-16 2015-05-20 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of (r)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
SI3925607T1 (sl) 2014-04-15 2023-10-30 Vertex Pharmaceuticals Incorporated Farmacevtski sestavki za zdravljenje bolezni, ki jih povzroča regulator transmembranske prevodnosti pri cistični fibrozi
CN115785079B (zh) * 2022-11-28 2024-02-13 沈阳药科大学 4-(1h-吲哚-5-基)氨基呋喃-2(5h)-酮类化合物及其制备和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU714873B2 (en) * 1995-08-02 2000-01-13 Newcastle University Ventures Limited Benzimidazole compounds
CO4970714A1 (es) * 1997-09-05 2000-11-07 Boehringer Mannheim Gmbh Derivados ureido y tioureido de 4-amino-2(5h)-furanonas y 4-amino-2(5h) tiofenonas como agentes antitumorales
DE19814838C2 (de) 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
NZ507406A (en) * 1998-04-28 2002-11-26 Dresden Arzneimittel New hydroxyindoles, their use as phosphodiesterase 4 (PDE4) inhibitors and a method of preparation

Also Published As

Publication number Publication date
JP2003519140A (ja) 2003-06-17
SK8962002A3 (en) 2002-11-06
DE60022227T2 (de) 2006-06-22
NO20022976L (no) 2002-06-20
IT1315267B1 (it) 2003-02-03
ES2246918T3 (es) 2006-03-01
NZ519689A (en) 2004-02-27
HUP0203524A2 (hu) 2003-03-28
CA2395205A1 (en) 2001-07-05
NO323312B1 (no) 2007-03-12
EP1244652B1 (en) 2005-08-24
IL150329A (en) 2006-07-05
IL150329A0 (en) 2002-12-01
US20030158153A1 (en) 2003-08-21
WO2001047916A1 (en) 2001-07-05
US6753342B2 (en) 2004-06-22
DE60022227D1 (de) 2005-09-29
HUP0203524A3 (en) 2008-01-28
MXPA02006217A (es) 2004-02-26
KR100795533B1 (ko) 2008-01-16
CN1250542C (zh) 2006-04-12
TR200201613T2 (tr) 2002-10-21
ZA200204964B (en) 2004-01-29
CN1413205A (zh) 2003-04-23
BR0016553A (pt) 2002-09-17
AU2170401A (en) 2001-07-09
PL356541A1 (en) 2004-06-28
SK285682B6 (sk) 2007-06-07
CZ20022170A3 (cs) 2002-09-11
EP1244652A1 (en) 2002-10-02
NO20022976D0 (no) 2002-06-20
ITMI992693A1 (it) 2001-06-23
KR20020063247A (ko) 2002-08-01
EA004925B1 (ru) 2004-10-28
ATE302772T1 (de) 2005-09-15
AU776332B2 (en) 2004-09-02
EA200200558A1 (ru) 2002-12-26

Similar Documents

Publication Publication Date Title
ITMI992693A0 (it) Derivati di 2-(1h-indol-3il)-2-oxo-acetammidi ad attivita' antitumoral e
DE60045321D1 (de) Mutilinderivate und deren Verwendung als antimikrobielle Agenzien
ITMI992188A0 (it) Combinazione di sostanze attive dotate di proprieta' insetticide ed ac ariche
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
DE60005810D1 (de) Fussstütze und möbelstück
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
ATE266374T1 (de) Kosmetische tensid-präparate und deren verwendung
ITMI981774A0 (it) Composizioni farmaceutiche ad attivita' analgesica
AR028281A1 (es) Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona
NO20013517D0 (no) Makrolider med anti-inflammatorisk aktivitet
PT1230230E (pt) Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico
DE60021507D1 (de) Uracilverbindungen und deren Verwendung
DE60038203D1 (de) Laserverstärker und Laseroszillator
ITMI20001697A0 (it) Ammidi di acidi 2-(1h-indol-3-il)-2-oxo-acetici ad attivita' antitumorale
ITTO20010110A0 (it) Nuovi derivati benzamidinici dotati di attivita' anti-infiammatoria ed immunosoppressiva.
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
ATE250339T1 (de) Dormanz-brechende zusammenstezung und deren verwendung
BR9911178B1 (pt) Derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenometil)-cefems, bem como preparação farmacêutica e uso dos mesmos
ITMI20000553A0 (it) Derivati di condensazione ad attivita' antitumorale loro metodo di preparazione e formulazioni che li contengono
DE60034963D1 (de) Heterocyclische derivate und arzneistoffe
NO20016030L (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
FR2798255B1 (fr) Support de culture subirrigant carrossable et horizontal
IT1293524B1 (it) Derivati di ammino-acridine carbossiammidi aventi attivita' antitumorale
IT1293523B1 (it) Derivati di pirazolo-acridine aventi attivita' antitumorale
ITRM990633A0 (it) Derivati polinucleari di ti(v) con leganti 4-acil-5-pirazolonati ad attivita' antitumorale e procedimento per la loro produzione.